NEW YORK (GenomeWeb News) – Nanosphere today said that revenues for full-year 2013 nearly doubled year over year, matching the consensus Wall Street estimate on the top line.

The Northbrook, Ill.-based firm said that it recorded $10.0 million in revenues for the year, up from $5.1 million in 2012. All revenues were derived from product sales, while grant and contract revenues declined to none in 2013 from $44,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.